Research groups
Dominic Oliver
PhD
Postdoctoral Researcher
I am a Postdoctoral Researcher working with Professor Philip McGuire. My interests lie in prevention of psychosis and other severe mental disorders, particularly in combining prediction modelling methods with routinely collected data to improve identification of individuals at risk, predict their clinical outcomes and their response to interventions.
My main role involves biomarker acquisition and analysis on the Stratification and Treatment in Early Psychosis (STEP) programme. STEP is three large scale, international multi-centre clinical trials of cannabidiol (CBD) in different stages of early psychosis: 1) Clinical high risk for psychosis; 2) First episode psychosis and; 3) Treatment resistant psychosis.
I completed my PhD in 2022 ("Improving prediction of psychosis risk") at the Institute of Psychiatry, Psychology & Neuroscience, King's College London, under the supervision of Professor Paolo Fusar-Poli and Professor Philip McGuire. In addition to colleagues at University of Oxford, I have continued collaborations at King's College London.
Key publications
-
Longitudinal evolution of the transdiagnostic prodrome to severe mental disorders: a dynamic temporal network analysis informed by natural language processing and electronic health records.
Journal article
Arribas M. et al, (2025), Mol Psychiatry
-
Using Electronic Health Records to Facilitate Precision Psychiatry.
Journal article
Oliver D. et al, (2024), Biol Psychiatry, 96, 532 - 542
-
Exploring causal mechanisms of psychosis risk.
Journal article
Oliver D. et al, (2024), Neurosci Biobehav Rev, 162
-
Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis
Journal article
Oliver D. et al, (2021), Schizophrenia Research, 227, 52 - 60
-
What Causes the Onset of Psychosis in Individuals at Clinical High Risk? A Meta-analysis of Risk and Protective Factors.
Journal article
Oliver D. et al, (2020), Schizophr Bull, 46, 110 - 120
Recent publications
-
The role of the electroencephalogram (EEG) in determining the aetiology of psychosis: a systematic review and meta-analysis of diagnostic test accuracy.
Journal article
Fanshawe JB. et al, (2025), Schizophr Res, 284, 48 - 58
-
Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.
Journal article
Chesney E. et al, (2025), Neuropsychopharmacology
-
It's About Time: Why We Need to Consider Temporal Drift When Developing and Implementing Clinical Prediction Models.
Journal article
Logeswaran Y. and Oliver D., (2025), Biol Psychiatry Cogn Neurosci Neuroimaging, 10, 677 - 678
-
Identification of menstrual psychosis cases using electronic health records.
Journal article
Reilly TJ. et al, (2025), Br J Psychiatry, 1 - 3
-
Cannabis Withdrawal and Psychiatric Intensive Care.
Journal article
Malik A. et al, (2025), JAMA Psychiatry